Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7,227,333
-
Total 13F shares
-
57,277,255
-
Share change
-
-126,468
-
Total reported value
-
$403,229,451
-
Put/Call ratio
-
0.49%
-
Price per share
-
$7.04
-
Number of holders
-
120
-
Value change
-
-$11,090,479
-
Number of buys
-
64
-
Number of sells
-
59
Institutional Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q4 2022
As of 31 Dec 2022 Kezar Life Sciences Inc - COMMON-STOCK (KZR) had 120 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 57,277,255 shares of stock of the company.
Largest 10 holders included Avidity Partners Management LP, ORBIMED ADVISORS LLC, STATE STREET CORP, BlackRock Inc., SUVRETTA CAPITAL MANAGEMENT, LLC, Bellevue Group AG, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, CHI Advisors LLC, and Prosight Management, LP.
This table shows 123 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.